Brooklyn ImmunoTherapeutics (BTX) Announces Howard J. Federoff, MD, PhD Appointed Chief Executive Officer
Go back to Brooklyn ImmunoTherapeutics (BTX) Announces Howard J. Federoff, MD, PhD Appointed Chief Executive OfficerBIOTIME, Inc. (NASDAQ: BTX) | Delayed: 0.21 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $0.21 | 52 Week High | $4.51 | |||
Open | $0.21 | 52 Week Low | $2.02 | |||
Day High | $0.21 | P/E | N/A | |||
Day Low | $0.21 | EPS | $-0.58 | |||
Volume | 2,808,386 |